| English Alias: |
PHENTOLAMINE MESYLATE;REGITIN;REGITIN MESYLATE;PHENTOLAMINE MESILATE;PHENTOLAMINE METHANESULFONATE;PHENTOLAMINE METHANESULFONATE SALT;VASOMAX;m-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)-phenomonomethanesulfonate(sal;Phentolamine (mesylate);Phentolamine Methane;2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline Methanesulfonate;3-[N-(2-Imidazolin-2-ylmethyl)-p-toluidino]phenol methanesulphonate;3,6,9,23,26,29,32,35,49,52,55,69,72,75,78,81,84-Heptadecaoxatridecacyclo[65.28.1.111,37.121,47.157,8;3,6,9,23,26,29,32,35,49,52,55,69,72,75,78,81,84-Heptadecaoxatridecacyclo[65.28.1.111,37.121,47.157,8;Phentolamine methanesulfonate;Phentolamine, methyl sulfonate;HMS3655B13;Phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt);Phentolamine mesilate for system suitability, European Pharmacopoeia (EP) Reference Standard;PHENTOLAMINE MESILATE (EP MONOGRAPH);Mesylate, Phentolamine;Phenol, m-(N-(2-imidazolin-2-ylmethyl)-p-toluidino)-, monomethanesulfonate (salt);SR-01000000055-3;P1985;NCGC00094282-01;P 7561;EN300-19630478;65-28-1;AC-7472;SR-01000000055;NV-101;s2038;Phentolamine mesylate, United States Pharmacopeia (USP) Reference Standard;HMS3373D03;3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(p-tolyl)amino)phenol methanesulfonate;EINECS 200-604-6;Mesylate phentolamine;BCP09845;Y7543E5K9T;HY-B0362A;LP00982;OraVerse;MFCD00134201;NCGC00261667-01;3-[N-(4,5-dihydro-1H-imidazol-1-ium-2-ylmethyl)-4-methylanilino]phenol;methanesulfonate;Z-Max;REGID_for_CID_91430;Phentolamine Mesylate, Pharmaceutical Secondary Standard; Certified Reference Material;Phentolamine mesylate [USP];1ST10275X-100M;Mesilate, Phentolamine;Regitine methanesulfonate;SW196637-3;PHENTOLAMINE MESILATE (MART.);Phentolamine mesilate (JAN/INN);AS-13800;PHENTOLAMINE MESYLATE (USP-RS);PHENTOLAMINE MESYLATE [USP MONOGRAPH];HMS3884A22;Opera_ID_1599;PHENTOLAMINE MESILATE [JAN];OGIYDFVHFQEFKQ-UHFFFAOYSA-N;Regitine (TN);SMR000059054;Vasofem;MLS000069487;AKOS007930193;PHENTOLAMINE MESYLATE (USP MONOGRAPH);3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol; methanesulfonic acid;HMS2233A24;Lopac-P-7561;Tox21_500982;PHENTOLAMINE METHANESULFONATE [MI];PHENOL, 3-(((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL)(4-METHYLPHENYL)AMINO)-, MONOMETHANESULPHONATE (SALT);SCHEMBL40852;MLS001076484;DTXCID60137806;Phentolamine mesylate (USP);2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline, methanesulfonate;Phenol, 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, monomethanesulfonate (salt);3-[4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol; methanesulfonic acid;Phentolamine Meslate,(S);PHENTOLAMINE MESYLATE [USP-RS];Phentolamine methanesulfonate salt, >=98% (TLC), powder;NCGC00016195-02;PHENTOLAMINE MESYLATE [ORANGE BOOK];W-104799;RYZUMVI;A835046;PHENTOLAMINE MESILATE [WHO-DD];HMS3263E05;Phentolamine mesilate, British Pharma... |
3-Thiophenecarboxylic acid, 5-(4-aminophenyl)-2-[[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino]-4-[(dimethylamino)methyl]-, ethyl ester, hydrochloride
Cas No: 2768834-98-4
1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
Cas No: 68077-26-9
2-Methyl-3-tritylamino-4-(2-N-bocamino)ethylaminoacarbonylamino-2H-pyrazole
Cas No: 689293-69-4
